Talis Biomedical Corporation announces expansion of Scientific Advisory Board

Published: Oct 11, 2018

 

Dr. Jane Schwebke, MD, joins the Talis SAB

 
 

MENLO PARK, Calif., Oct. 11, 2018 /PRNewswire/ -- Talis Biomedical Corporation is pleased to announce the expansion of their Scientific Advisory Board and the appointment of Dr. Jane Schwebke, MD, Professor of Medicine in the Infectious Disease Division at the University of Alabama at Birmingham and Consultant to the Jefferson County Department of Health STD clinic.

Talis Biomedical (PRNewsfoto/Talis Biomedical Corporation)

 

Talis is driven by the mission to transform medical care by enabling rapid molecular testing in the near patient setting.  

Dr. Schwebke will work closely with the Talis team and with Dr. Rustem Ismagilov, chair of the SAB, to advance the mission in the areas of sexually transmitted infections and Women's Health.

Brian Coe, Talis' Chief Executive Officer, stated: "We are honored to announce the expansion of our Scientific Advisory Board. It is a testament of the scientific and clinical enthusiasm for our pioneering solution, and we are privileged to welcome Dr. Jane Schwebke to our SAB."  

Dr. Schwebke stated, "I am very excited to serve on the Talis SAB. There is a critical need for rapid STD and women's health diagnostic testing and I believe Talis will provide the solution."

About Dr. Schwebke:
Dr. Schwebke received her medical degree from Northwestern University Feinberg School of Medicine and has been in practice for more than 20 years. She began her career in the field of STDs in 1987 during her fellowship in Infectious Disease at the University of Washington in Seattle. After her fellowship she became the medical director of the Harborview STD Clinic in Seattle where she remained until April 1991. She subsequently had a joint appointment at Northwestern University in Chicago and the Chicago Department of Health where she became the Director for the City of Chicago's STD/HIV Program. Important contributions to the Program included merging STD and HIV, initiating HIV clinical care in the city's clinics, initiation of cervical cancer screening in the STD clinics, creation of a clinical and behavioral research program, development of an adolescent clinic combining STD, HIV, and contraception services for Hispanic youth and addition of TB skin testing for STD clinic patients. She has been a faculty member at the University of Alabama at Birmingham for the past 24 years. Her major areas of research include the pathogenesis of bacterial vaginosis and its relationship to the acquisition of STDs as well as epidemiology and control of trichomoniasis.

About Talis
Talis is developing a new class of diagnostic platforms to enable rapid, molecular testing across a wide range of healthcare settings. Our visionary team combines depth of experience with passion to deliver a pioneering solution to infectious disease diagnostics. Reach out for partnership opportunities at www.talis.bio/partners.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/talis-biomedical-corporation-announces-expansion-of-scientific-advisory-board-300729601.html

SOURCE Talis

 

Back to news